A double-blind, placebo-controlled, randomised trial to determine the ocular pharmacokinetics and safety of oral FT011 in patients with glaucoma.
Phase of Trial: Phase I
Latest Information Update: 06 Jun 2019
Price : $35 *
At a glance
- Drugs SHP 627 (Primary)
- Indications Glaucoma
- Focus Pharmacokinetics
- Sponsors OccuRx
- 04 Jun 2019 Status changed from not yet recruiting to recruiting.
- 08 Jan 2019 Planned initiation date changed from 1 Feb 2018 to 31 Jan 2019.
- 15 Jan 2018 New trial record